US Stock MarketDetailed Quotes

TXG 10x Genomics

Watchlist
  • 28.950
  • -0.210-0.72%
Close Apr 18 16:00 ET
  • 29.200
  • +0.250+0.86%
Post 19:45 ET
3.45BMarket Cap-13279P/E (TTM)

10x Genomics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
19.81%618.73M
17.76%183.98M
17.22%153.64M
28.10%146.82M
17.28%134.29M
5.28%516.41M
8.85%156.23M
4.61%131.07M
-1.06%114.61M
8.20%114.5M
Operating revenue
19.81%618.73M
17.76%183.98M
17.22%153.64M
28.10%146.82M
17.28%134.29M
5.28%516.41M
8.85%156.23M
4.61%131.07M
-1.06%114.61M
8.20%114.5M
Cost of revenue
73.95%209.41M
85.18%68.2M
91.31%58.12M
70.40%47.21M
40.89%35.9M
62.48%120.39M
33.44%36.83M
23.90%30.38M
463.66%27.7M
49.34%25.48M
Gross profit
3.36%409.31M
-3.03%115.78M
-5.13%95.53M
14.62%99.61M
10.53%98.39M
-4.89%396.02M
3.00%119.41M
-0.08%100.7M
-21.66%86.91M
0.29%89.02M
Operating expense
19.62%674.64M
19.98%170.97M
35.28%190.32M
8.63%162.97M
15.01%150.38M
20.17%563.97M
8.15%142.5M
20.60%140.69M
22.86%150.02M
32.36%130.75M
Selling and administrative expenses
15.10%343.33M
9.18%86.13M
12.28%82.42M
15.34%91.51M
24.90%83.28M
15.82%298.3M
12.89%78.89M
18.24%73.4M
15.48%79.34M
17.17%66.68M
Research and development costs
24.71%331.31M
33.37%84.85M
60.36%107.91M
1.10%71.46M
4.71%67.1M
25.46%265.67M
2.79%63.61M
23.28%67.29M
32.36%70.69M
52.99%64.08M
Operating profit
-57.99%-265.33M
-138.95%-55.19M
-137.01%-94.8M
-0.38%-63.36M
-24.57%-51.99M
-217.40%-167.94M
-45.90%-23.1M
-151.88%-40M
-464.65%-63.12M
-316.27%-41.74M
Net non-operating interest income expense
173.42%16.87M
72.08%4.63M
124.96%4.3M
262.71%4.1M
773.02%3.85M
1,035.00%6.17M
1,701.19%2.69M
1,224.12%1.91M
847.68%1.13M
357.89%441K
Non-operating interest income
154.34%16.91M
64.72%4.64M
112.35%4.3M
231.18%4.1M
579.96%3.87M
3,126.70%6.65M
5,644.90%2.82M
4,032.65%2.03M
2,034.48%1.24M
1,038.00%569K
Non-operating interest expense
-93.07%33K
-93.60%8K
-99.12%1K
-95.41%5K
-85.16%19K
-45.03%476K
-42.40%125K
-47.95%114K
-47.85%109K
-42.08%128K
Other net income (expense)
-55.05%-307K
-0.85%3.96M
36.00%-1.25M
18.39%-1.5M
-279.00%-1.52M
-39.44%-198K
79,800.00%4M
-225.54%-1.95M
-234.43%-1.84M
56.47%-400K
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
-Less:Restructuring and merger&acquisition
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-55.05%-307K
-0.85%3.96M
36.00%-1.25M
18.39%-1.5M
-279.00%-1.52M
75.31%-198K
79,800.00%4M
-225.54%-1.95M
-453.74%-1.84M
45.13%-400K
Income before tax
-53.58%-248.76M
-183.94%-46.6M
-129.16%-91.74M
4.80%-60.77M
-19.09%-49.65M
-201.54%-161.97M
-2.61%-16.41M
-140.48%-40.04M
-541.00%-63.83M
-275.08%-41.69M
Income tax
57.26%6.34M
192.79%2.35M
-33.90%1.24M
162.68%1.65M
52.02%1.09M
-10.63%4.03M
-67.26%804K
259.27%1.88M
-42.69%627K
65.29%719K
Net income
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
Net income continuous Operations
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
Minority interest income
Net income attributable to the parent company
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
Basic earnings per share
-49.32%-2.18
-173.33%-0.41
-113.51%-0.79
7.02%-0.53
-15.79%-0.44
-175.47%-1.46
6.25%-0.15
-146.67%-0.37
-470.00%-0.57
-245.45%-0.38
Diluted earnings per share
-49.32%-2.18
-173.33%-0.41
-113.51%-0.79
7.02%-0.53
-15.79%-0.44
-175.47%-1.46
6.25%-0.15
-146.67%-0.37
-470.00%-0.57
-245.45%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 19.81%618.73M17.76%183.98M17.22%153.64M28.10%146.82M17.28%134.29M5.28%516.41M8.85%156.23M4.61%131.07M-1.06%114.61M8.20%114.5M
Operating revenue 19.81%618.73M17.76%183.98M17.22%153.64M28.10%146.82M17.28%134.29M5.28%516.41M8.85%156.23M4.61%131.07M-1.06%114.61M8.20%114.5M
Cost of revenue 73.95%209.41M85.18%68.2M91.31%58.12M70.40%47.21M40.89%35.9M62.48%120.39M33.44%36.83M23.90%30.38M463.66%27.7M49.34%25.48M
Gross profit 3.36%409.31M-3.03%115.78M-5.13%95.53M14.62%99.61M10.53%98.39M-4.89%396.02M3.00%119.41M-0.08%100.7M-21.66%86.91M0.29%89.02M
Operating expense 19.62%674.64M19.98%170.97M35.28%190.32M8.63%162.97M15.01%150.38M20.17%563.97M8.15%142.5M20.60%140.69M22.86%150.02M32.36%130.75M
Selling and administrative expenses 15.10%343.33M9.18%86.13M12.28%82.42M15.34%91.51M24.90%83.28M15.82%298.3M12.89%78.89M18.24%73.4M15.48%79.34M17.17%66.68M
Research and development costs 24.71%331.31M33.37%84.85M60.36%107.91M1.10%71.46M4.71%67.1M25.46%265.67M2.79%63.61M23.28%67.29M32.36%70.69M52.99%64.08M
Operating profit -57.99%-265.33M-138.95%-55.19M-137.01%-94.8M-0.38%-63.36M-24.57%-51.99M-217.40%-167.94M-45.90%-23.1M-151.88%-40M-464.65%-63.12M-316.27%-41.74M
Net non-operating interest income expense 173.42%16.87M72.08%4.63M124.96%4.3M262.71%4.1M773.02%3.85M1,035.00%6.17M1,701.19%2.69M1,224.12%1.91M847.68%1.13M357.89%441K
Non-operating interest income 154.34%16.91M64.72%4.64M112.35%4.3M231.18%4.1M579.96%3.87M3,126.70%6.65M5,644.90%2.82M4,032.65%2.03M2,034.48%1.24M1,038.00%569K
Non-operating interest expense -93.07%33K-93.60%8K-99.12%1K-95.41%5K-85.16%19K-45.03%476K-42.40%125K-47.95%114K-47.85%109K-42.08%128K
Other net income (expense) -55.05%-307K-0.85%3.96M36.00%-1.25M18.39%-1.5M-279.00%-1.52M-39.44%-198K79,800.00%4M-225.54%-1.95M-234.43%-1.84M56.47%-400K
Special income (charges) --0------------------0----------------
-Less:Restructuring and merger&acquisition --0------------------0----------------
Other non- operating income (expenses) -55.05%-307K-0.85%3.96M36.00%-1.25M18.39%-1.5M-279.00%-1.52M75.31%-198K79,800.00%4M-225.54%-1.95M-453.74%-1.84M45.13%-400K
Income before tax -53.58%-248.76M-183.94%-46.6M-129.16%-91.74M4.80%-60.77M-19.09%-49.65M-201.54%-161.97M-2.61%-16.41M-140.48%-40.04M-541.00%-63.83M-275.08%-41.69M
Income tax 57.26%6.34M192.79%2.35M-33.90%1.24M162.68%1.65M52.02%1.09M-10.63%4.03M-67.26%804K259.27%1.88M-42.69%627K65.29%719K
Net income -53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M-144.10%-41.91M-483.22%-64.46M-267.18%-42.41M
Net income continuous Operations -53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M-144.10%-41.91M-483.22%-64.46M-267.18%-42.41M
Minority interest income
Net income attributable to the parent company -53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M-144.10%-41.91M-483.22%-64.46M-267.18%-42.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M-144.10%-41.91M-483.22%-64.46M-267.18%-42.41M
Basic earnings per share -49.32%-2.18-173.33%-0.41-113.51%-0.797.02%-0.53-15.79%-0.44-175.47%-1.466.25%-0.15-146.67%-0.37-470.00%-0.57-245.45%-0.38
Diluted earnings per share -49.32%-2.18-173.33%-0.41-113.51%-0.797.02%-0.53-15.79%-0.44-175.47%-1.466.25%-0.15-146.67%-0.37-470.00%-0.57-245.45%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg